A phase II trial for patients with traumatic brain injury (TBI) will aim to break the impasse of 30 years of failed clinical trials for TBI. The study will compare the effects of off-label drugs that have been found to be effective in animal studies.
The UC Board of Regents approved UCSF’s proposal to build a proton therapy facility as part of the redevelopment of the former Dogpatch Power Station, which will join only 45 other sites nationwide and will be the only facility to offer the leading-edge cancer therapy between Los Angeles and Seattle.
UCSF Health is once again recognized by Vizient Inc. as a leader in health care quality.
David Julius and Wendy Yue have discovered a natural mechanism that could help reduce scarring after a spinal cord injury.
Black men are more than twice as likely to die of prostate cancer than their white peers. An innovative community-based UCSF program is increasing screenings among San Francisco's Black communities.
UCSF Health’s new Bayfront Medical Building features interactive art installations including a soundscape mural and a sound sculpture, enhancing the healing environment for patients, families, and healthcare providers.
Powerful electron microscopy and 3D imaging leads scientists to a new discovery showing how the TGF-Beta signaling protein is able to move much more freely than previously thought.
Since 2020, the Center for Health Equity in Surgery and Anesthesia has used research, education and advocacy to improve access to safe surgical, anesthetic and perioperative care in underserved areas of the U.S. and globally, as well as build a pipeline of care providers from diverse backgrounds.
John Clements, MD, whose scientific discoveries helped save millions of newborns around the world from respiratory distress syndrome and whose boundless appetite for learning helped create the interdisciplinary culture at UCSF, has died on Sept. 3, 2024 at the age of 101.
A new study is projecting that the number of people in the U.S. with atrial fibrillation, a common precursor to stroke, is about three times higher than previous estimates. An estimated 35% of people with a-fib will have a stroke.
